Drug Shortage Report for PMS-RISEDRONATE
Report ID | 69240 |
Drug Identification Number | 02302209 |
Brand name | PMS-RISEDRONATE |
Common or Proper name | RISEDRONATE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-12-11 |
Estimated end date | 2019-04-12 |
Actual end date | 2019-05-07 |
Shortage status | Resolved |
Updated date | 2019-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-05-09 | French | Compare |
v8 | 2019-05-09 | English | Compare |
v7 | 2019-03-29 | French | Compare |
v6 | 2019-03-29 | English | Compare |
v5 | 2019-01-16 | French | Compare |
v4 | 2019-01-16 | English | Compare |
v3 | 2018-12-12 | English | Compare |
v2 | 2018-12-11 | French | Compare |
v1 | 2018-12-11 | English | Compare |
Showing 1 to 9 of 9